Peerschke, E.I.; Stanchina, E.d.; Chang, Q.; Manova-Todorova, K.; Barlas, A.; Savitt, A.G.; Geisbrecht, B.V.; Ghebrehiwet, B.
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies 2020, 9, 51.
https://doi.org/10.3390/antib9040051
AMA Style
Peerschke EI, Stanchina Ed, Chang Q, Manova-Todorova K, Barlas A, Savitt AG, Geisbrecht BV, Ghebrehiwet B.
Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies. 2020; 9(4):51.
https://doi.org/10.3390/antib9040051
Chicago/Turabian Style
Peerschke, Ellinor I., Elisa de Stanchina, Qing Chang, Katia Manova-Todorova, Afsar Barlas, Anne G. Savitt, Brian V. Geisbrecht, and Berhane Ghebrehiwet.
2020. "Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer" Antibodies 9, no. 4: 51.
https://doi.org/10.3390/antib9040051
APA Style
Peerschke, E. I., Stanchina, E. d., Chang, Q., Manova-Todorova, K., Barlas, A., Savitt, A. G., Geisbrecht, B. V., & Ghebrehiwet, B.
(2020). Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer. Antibodies, 9(4), 51.
https://doi.org/10.3390/antib9040051